EUCTR2021-002813-33-IT招募中1 期
Early use of dapaglifozin in diabetic patients with acute myocardial infarction and reduced ejection fraction: the randomized ARMYDA-9 DAPA trial - ARMYDA-9 DAPA trial
AZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITà DI NOVARA0 个研究点目标入组 140 人开始时间: 2022年1月27日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Type 2 diabetes mellitus
- •ST-elevate myocardial infarction
- •Percutaneous coronary angioplasty <12 hours from symptom onset
- •TIMI coronary flow 0-1 at the time of primary PCI
- •Left ventricle ejection fraction 40% assessed within 12 hours from admission
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 70
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 70
排除标准
- •Cardiogenic shock
- •Symptomatic hypotension
- •History of restrictive cardiomyopathy, constrictive pericarditis, or untreated severe heart valve disease
- •History of diabetic ketoacidosis, secondary diabetes or type 1 diabetes
- •Severe hepatic insufficiency
- •Active cancer
- •eGFR<30 ml/min
研究者
相似试验
已完成
不适用
The potential effect of Dapagliflozin on diabetic macular edemadiabetic macular edema, diabetesJPRN-UMIN000020331Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism45
尚未招募
4 期
Dapagliflozin in Acute Heart failureIRCT20220529055013N1Public Sector medical University160
招募中
3 期
Efficacy of anti diabetic drug (Dapagliflozin) in patients with Diabetic periphral neuropathyCTRI/2022/06/043236Postgraduate Institute of Medical Education Research
已完成
不适用
Effect of Dapagliflozin in patients with type 2 daibetes mellitusType 2 diabetes mellitusJPRN-UMIN000014922Iwasaki Naika Clinic50
招募中
2 期
A single-site study of the effectiveness of Dapagliflozin for diabetic patients admitted to the intensive care unitMetabolic and Endocrine - DiabetesDiabetesACTRN12621001102864Austin Health40